Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: Results of a randomized clinical trial

1. Gomez-Martin, C.
2. Solá, C.
3. Hornedo, J.
4. Perea, S.
5. Lumbreras, C.
6. Valentí, V.
7. Arcediano, A.
8. Rodriguez, M.
9. Salazar, R.
10. Cortés-Funes, H.
11. Hidalgo, M.